PharmaTher Holdings
Toronto, US · Founded 2019 · British Columbia, Canada corporation
Pharmather develops personalized therapeutic treatments, focusing on ketamine and cepharanthine-based therapies for mental health and other conditions.
Founders & leadership
PharmaTher Holdings was founded in 2019 by FABIO CHIANELLI.
Board
CS
CARLO SANSALONEBoard director
BJ
BEVERLY JAMES INCLEDONBoard director
CS
CHRISTIAN SCOVENNABoard director
Reported raises · per SEC filings
Form D private placements$7.9M disclosed across 1 round · 2021
▶$7.9MraisedOct 2021 · 2 investors · BiotechnologyRule 506(b)
▶$7.9MraisedOct 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- CARLO SANSALONEDirector
- BEVERLY JAMES INCLEDONDirector
- FABIO CHIANELLIExecutive Officer, Director
- CHRISTIAN SCOVENNADirector
- ANDREW NEWBURYExecutive Officer
- CARMELO MARRELLIExecutive Officer
- Offering amount
- $17.7M
- Amount sold
- $7.9M
- Finders' fees
- $630.9K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, British Columbia, Canada, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does PharmaTher Holdings do?
- Pharmather develops personalized therapeutic treatments, focusing on ketamine and cepharanthine-based therapies for mental health and other conditions.
- Who founded PharmaTher Holdings?
- PharmaTher Holdings was founded by FABIO CHIANELLI in 2019.
- How much funding has PharmaTher Holdings raised?
- PharmaTher Holdings has disclosed $7.9M raised across 1 round.
- Where is PharmaTher Holdings headquartered?
- PharmaTher Holdings is headquartered in Toronto, US.